Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Annals of the American Thoracic Society|April 15, 2015
Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthmaAmani I El-Gammal, Kieran J Killian, Tara X Scime, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2010
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthmaGail M Gauvreau, Louis-Philippe Boulet, Donald W Cockcroft, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 18, 2014
Prevalence and determinants of atopy and allergic diseases among school-age children in rural Saskatchewan, CanadaLuan M Chu, Donna C Rennie, Donald W Cockcroft, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
The Journal of Allergy and Clinical Immunology|August 5, 2003
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthmaGail M Gauvreau, Allan B Becker, Louis-Philippe Boulet, et al.
Human Pathology|December 3, 2014
Pulmonary fibrosis in dyskeratosis congenita: report of 2 casesLeah A Dvorak, Robert Vassallo, Salman Kirmani, et al.
The European Respiratory Journal|July 26, 2024
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trialGail M Gauvreau, Roma Sehmi, J Mark FitzGerald, et al.
American Journal of Respiratory and Critical Care Medicine|February 5, 2008
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responsesGail M Gauvreau, Louis Philippe Boulet, Donald W Cockcroft, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthmaPaul M O'Byrne, Just van der Linde, Donald W Cockcroft, et al.
The European Respiratory Journal|May 3, 2017
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge testsAllan L Coates, Jack Wanger, Donald W Cockcroft, et al.
Pageof 10